Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis

BackgroundThe PACIFIC regimen (consolidation durvalumab following chemoradiotherapy) is the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). With the publication of data from the phase III LAURA trial and the emergence of real-world evidence regarding sequential toxici...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yang Yang, Jinhan Sun, Ting Luo, Xinfu Liu, Yanyang Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-06-01
Col·lecció:	Frontiers in Oncology
Matèries:	chemoradiotherapy EGFR mutations EGFR-TKIs network meta-analysis unresectable stage III NSCLC
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1852617/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!